Datta D, Vlavianos P, Alisa A, Westaby D
Dept. of Gastroenterology, Chelsea and Westminster Hospital, London, UK.
Endoscopy. 2003 Aug;35(8):675-8. doi: 10.1055/s-2003-41517.
Gastric variceal bleeding is a serious complication of portal hypertension. The optimum endoscopic treatment of bleeding gastric varices is yet to be defined. We evaluated the use of Beriplast, which is a solution of fibrinogen and thrombin, in controlling gastric variceal bleeding.
Fifteen patients presenting with gastric variceal bleeding were entered into an open trial of endoscopic gastric intravariceal injection treatment with Beriplast (fibrin sealant) and followed for up to 1 month after endoscopic treatment.
There was failure to control bleeding in one patient. Four patients had rebleeding after the index bleed. All four were reinjected with Beriplast, and the bleeding was controlled in three. All patients were followed for 30 days, and the 30-day mortality following injection treatment was one. Fourteen patients were discharged from the hospital after the first episode of gastric variceal bleeding. None of the patients had injection-induced complications.
These results show that Beriplast is a safe and simple endoscopic treatment option and is very effective in controlling gastric variceal bleeding.
胃静脉曲张出血是门静脉高压的严重并发症。胃静脉曲张出血的最佳内镜治疗方法尚未确定。我们评估了纤维蛋白原和凝血酶溶液贝瑞普利素(Beriplast)在控制胃静脉曲张出血中的应用。
15例胃静脉曲张出血患者进入贝瑞普利素(纤维蛋白封闭剂)内镜下胃静脉曲张内注射治疗的开放试验,并在内镜治疗后随访长达1个月。
1例患者出血未能得到控制。4例患者在首次出血后再次出血。所有4例均再次注射贝瑞普利素,其中3例出血得到控制。所有患者均随访30天,注射治疗后的30天死亡率为1例。14例患者在首次胃静脉曲张出血发作后出院。所有患者均未出现注射引起的并发症。
这些结果表明,贝瑞普利素是一种安全、简单的内镜治疗选择,在控制胃静脉曲张出血方面非常有效。